Implementation of good distribution practice in a Thai pharmaceutical manufacturer

Good distribution practice (GDP) has recently been adopted and practiced by the pharmaceutical industry in Thailand, complementing the supply chain perspective and fundamentally transforming the industry’s quality landscape. This study proposed a GDP implementation methodology that integrates project management and quality risk management (QRM) to effectively identify, manage, and mitigate distribution risks. The project management framework provides valuable tools and approaches for prioritizing operational gaps, managing expectations, and securing necessary resources, while QRM focuses on the risk aspects such as operation impact, reputation, and cost for manufacturers. The methodology was successfully applied to a pharmaceutical manufacturer to ensure product quality during storage and distribution and to prevent counterfeit products from infiltrating the supply chain. This study provides 4 insights into GDP implementations: (1) fostering a project management culture, (2) utilizing existing templates and tools, (3) implementing continuous compliance monitoring, and (4) embracing digital transformation through information technology systems. This implementation represents an opportunity to engage executives and extend the quality program beyond manufacturing into logistic activities.

Authors

Institutions

Publication Details

Journal
Science, Engineering and Health Studies
Published
2024-11-20
DOI
https://doi.org/10.69598/sehs.18.24040003
Primary Topic
Quality and Supply Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Implementation of good distribution practice in a Thai pharmaceutical manufacturer

Oran Kittithreerapronchai, Pana Chinajitphan
Science, Engineering and Health Studies
Quality and Supply Management
article

Implementation of good distribution practice in a Thai pharmaceutical manufacturer

Oran Kittithreerapronchai, Pana Chinajitphan
article en

Abstract

Good distribution practice (GDP) has recently been adopted and practiced by the pharmaceutical industry in Thailand, complementing the supply chain perspective and fundamentally transforming the industry’s quality landscape. This study proposed a GDP implementation methodology that integrates project management and quality risk management (QRM) to effectively identify, manage, and mitigate distribution risks. The project management framework provides valuable tools and approaches for prioritizing operational gaps, managing expectations, and securing necessary resources, while QRM focuses on the risk aspects such as operation impact, reputation, and cost for manufacturers. The methodology was successfully applied to a pharmaceutical manufacturer to ensure product quality during storage and distribution and to prevent counterfeit products from infiltrating the supply chain. This study provides 4 insights into GDP implementations: (1) fostering a project management culture, (2) utilizing existing templates and tools, (3) implementing continuous compliance monitoring, and (4) embracing digital transformation through information technology systems. This implementation represents an opportunity to engage executives and extend the quality program beyond manufacturing into logistic activities.

Science, Engineering and Health Studies
Chulalongkorn University (TH)
Decent work and economic growth
Openalex Percentile: Top 68%
Quality and Supply Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Implementation of good distribution practice in a Thai pharmaceutical manufacturer — Oran Kittithreerapronchai, Pana Chinajitphan · Science, Engineering and Health Studies (2024) | TGRS Research Map | TGRS